 Evaluation serum CA tumor marker non-small cell lung cancer Serum CA levels healthy subjects patients untreated pulmonary lesions patients benign pulmonary conditions lung cancer mean concentration CA patients lung cancer U/ml nonmalignant disease U/ml healthy control group CA concentrations U/ml patients lung cancer concentration tumor marker tumor-node-metastasis TNM stage cut-off value U/ml CA sensitivity specificity positive predictive value negative predictive value respect healthy subjects patients benign pulmonary conditions values cut-off value correlation respectability prognosis likelihood survival months posttreatment findings CA adjunctive test management patients lung cancer patients